NAT10 and sarcoma: Kaplan–Meier survival analysis from the The Cancer Genome Atlas (TCGA) dataset http://www.oncolnc.org/) showed that sarcoma patients with low NAT10 expression exhibited a superior survival, while sarcoma patients with high NAT10 expression exhibited poor survival rate (Fig. 2B).